lunes, 25 de noviembre de 2024
Trump picks Johns Hopkins surgeon Makary to run FDA Makary has made a name for himself by challenging status quo ideas in the medical establishment.
Trump picks Johns Hopkins surgeon Makary to run FDA
Makary has made a name for himself by challenging status quo ideas in the medical establishment.
https://www.statnews.com/2024/11/22/trump-fda-nominee-marty-makary-surgeon-maha-ally-rfk-jr/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_gyVUMMcincpmi2m6mYrlMGMmZeRD1W0CdCB-4QkeELMi3z-Hiv9Svcv9x-Z1E-DwxCVyEJECyMGRhvOd5Ku6N4p9SgQ&_hsmi=335470246&utm_content=335470246&utm_source=hs_email
FDA
Trump tapped surgeon Martin “Marty” Makary to lead the FDA. STAT’s Rachel Cohrs Zhang rounded up seven examples from Makary's history of criticizing the agency, including calling out the FDA’s decisions to approve boosters for young people, the pace of its approval for early vaccines, and its remote work policies.
Makary is also an executive of the telehealth company Sesame, which connects consumers to physicians who can prescribe compounded weight-loss drugs. If confirmed as FDA commissioner, he would take the lead of the agency as it grapples with high-stakes policy issues that could impact Sesame’s business. Read more from a team of STAT reporters on that potential conflict.
While Matt wrote that the CDC is “in big trouble,” under Weldon, he believes that the FDA “might be OK” under Makary. Leaders in biotech and pharma were a little more optimistic: “We dodged a bullet,” one biotech investor told STAT reporters. Read Matt’s Take and more biotech and pharma reactions.
Trump’s pick to run FDA is top exec of company that provides compounded weight-loss drugs
If confirmed as FDA commissioner, Makary would take the lead of the agency as it grapples with high-stakes policy issues that could impact Sesame’s business
https://www.statnews.com/2024/11/24/makary-sesame-compounded-weight-loss-drugs-semaglutide-fda-shortage-list/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-8wWMqhaP_0kGYpa8Ly8vQ16cohvkmsNzSheXJmZ5rtT4FfdCwwW6Px0Ia_-g3Kl4UAUuIlin4I0dhzi1-vtWvwtLnIbQ&_hsmi=335470246&utm_content=335470246&utm_source=hs_email
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario